XML 32 R14.htm IDEA: XBRL DOCUMENT
v3.22.2.2

IMPAIRMENT, RESTRUCTURING AND OTHER | 12 Months Ended
--- | ---
Sep. 30, 2022
Restructuring and Related Activities [Abstract] |
IMPAIRMENT, RESTRUCTURING AND OTHER | IMPAIRMENT, RESTRUCTURING AND OTHER Activity described herein is classified within the “Cost of sales—impairment, restructuring and other,” “Impairment, restructuring and other” and “Income (loss) from discontinued operations, net of tax” lines in the Consolidated Statements of Operations. The following table details impairment, restructuring and other charges (recoveries) for each of the periods presented:
| Year Ended September 30,
| 2022 |  | 2021 |  | 2020
Cost of sales—impairment, restructuring and other: |  |  |  |  |
COVID-19 related costs | $ | — |  |  | $ | 25.0 |  |  | $ | 15.5 |
Restructuring and other charges (recoveries), net | 143.6 |  |  | (0.3) |  |  | (0.1) |
Property, plant and equipment impairments | 16.6 |  |  | — |  |  | 0.6 |
Operating expenses—impairment, restructuring and other: |  |  |  |  |
COVID-19 related costs | — |  |  | 4.2 |  |  | 3.9 |
Restructuring and other charges (recoveries), net | 40.9 |  |  | 0.1 |  |  | (3.1) |
Gains on sale of property, plant and equipment | (16.2) |  |  | — |  |  | — |
Goodwill and intangible asset impairments | 668.3 |  |  | — |  |  | — |
Impairment, restructuring and other charges from continuing operations | 853.2 |  |  | 29.0 |  |  | 16.8 |
Restructuring and other charges (recoveries), net, from discontinued operations | — |  |  | — |  |  | (3.1) |
Total impairment, restructuring and other charges | $ | 853.2 |  |  | $ | 29.0 |  |  | $ | 13.7 |
The following table summarizes the activity related to liabilities associated with restructuring activities for each of the periods presented:
| Year Ended September 30,
| 2022 |  | 2021 |  | 2020
Amounts accrued for restructuring activities at beginning of year | $ | 1.9 |  |  | $ | 3.9 |  |  | $ | 11.6 |
Restructuring and other charges from continuing operations | 47.1 |  |  | 29.0 |  |  | 20.0 |
Payments and other | (17.5) |  |  | (31.0) |  |  | (27.7) |
Amounts accrued for restructuring activities at end of year | $ | 31.5 |  |  | $ | 1.9 |  |  | $ | 3.9 |
Included in restructuring accruals, as of September 30, 2022, is $4.6 that is classified as long-term. The remaining amounts accrued will continue to be paid out over the course of the next twelve months. During fiscal 2022, the Company recognized non-cash, pre-tax goodwill and intangible asset impairment charges of $632.4 as a result of interim impairment testing of its Hawthorne segment in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations, comprised of $522.4 of goodwill impairment charges and $110.0 of finite-lived intangible asset impairment charges. During fiscal 2022, the Company incurred inventory write-down charges of $120.9 in the “Cost of sales—impairment, restructuring and other” line in the Consolidated Statements of Operations and finite-lived intangible asset impairment charges of $35.3 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations associated with its decision to discontinue and exit the market for certain Hawthorne lighting products and brands. During fiscal 2022, the Company began implementing a series of organizational changes and initiatives intended to create operational and management-level efficiencies. As part of this restructuring program, the Company is reducing the size of its supply chain network, reducing staffing levels and implementing other cost-reduction initiatives. During fiscal 2022, the Company incurred costs of $65.2 associated with this restructuring initiative primarily related to employee termination benefits and impairment of property, plant and equipment. The Company incurred costs of $9.7 in its U.S. Consumer segment and $27.1 in its Hawthorne segment in the “Cost of sales—impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2022. The Company incurred costs of $11.9 in its U.S. Consumer segment, $8.1 in its Hawthorne segment, $0.7 in its Other segment and $7.7 at Corporate in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2022. During fiscal 2022, the Company recognized gains of $16.2 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations associated with the sale of property, plant and equipment. Costs incurred during fiscal 2022 related to COVID-19 were immaterial. During 2021, the Company incurred costs of $29.2 associated with the COVID-19 pandemic primarily related to premium pay. The Company incurred costs of $21.2 in its U.S. Consumer segment, $3.2 in its Hawthorne segment and $0.6 in its Other segment in the “Cost of sales—impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2021. The Company incurred costs of $4.0 in its U.S. Consumer segment and $0.2 in its Other segment in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2021. During fiscal 2020, the Company incurred costs of $19.4 associated with the COVID-19 pandemic primarily related to premium pay. The Company incurred costs of $12.4 in its U.S. Consumer segment, $2.6 in its Hawthorne segment and $0.5 in its Other segment in the “Cost of sales—impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2020. The Company incurred costs of $3.8 in its U.S. Consumer segment and $0.1 in its Other segment in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2020.

X
- References No definition available. + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets. + References No definition available. + Details
Name: | us-gaap_RestructuringImpairmentAndOtherActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration